IGFBP1 and myocardial infarction: In T2D patients surviving acute myocardial infarction (n = 1253, mean 70 y, 33% F), higher levels of IGFBP-1 at admission predicted cardiovascular morbidity and mortality during a median follow-up of two years [72].